Page last updated: 2024-10-29

ketanserin and Affective Disorders

ketanserin has been researched along with Affective Disorders in 2 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frokjaer, VG1
Vinberg, M1
Erritzoe, D1
Baaré, W1
Holst, KK1
Mortensen, EL1
Arfan, H1
Madsen, J1
Jernigan, TL1
Kessing, LV1
Knudsen, GM1
Biegon, A1
Essar, N1
Israeli, M1
Elizur, A1
Bruch, S1
Bar-Nathan, AA1

Other Studies

2 other studies available for ketanserin and Affective Disorders

ArticleYear
Familial risk for mood disorder and the personality risk factor, neuroticism, interact in their association with frontolimbic serotonin 2A receptor binding.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010, Volume: 35, Issue:5

    Topics: Adult; Family; Female; Frontal Lobe; Genetic Predisposition to Disease; Humans; Ketanserin; Limbic S

2010
Serotonin 5-HT2 receptor binding on blood platelets as a state dependent marker in major affective disorder.
    Psychopharmacology, 1990, Volume: 102, Issue:1

    Topics: Adult; Aged; Biomarkers; Blood Platelets; Cell Membrane; Depressive Disorder; Female; Humans; Ketans

1990